Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-Bio-ADAURA: a Single Arm, Multi-Centre Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib.

NCT06206850 is registered in ClinicalTrials.gov with Jair Bar, M.D., Ph.D. as lead sponsor.

NCT NCT06206850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06206850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-Bio-ADAURA: a Single Arm, Multi-Centre Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib.
Lead sponsor
Jair Bar, M.D., Ph.D.
Phase
Phase 2
Overall status
Recruiting
Start date
February 19, 2024
Completion date
January 1, 2030
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous nsclc